STAT3 and hepatocellular carcinoma: In conclusion, the present findings indicate that the anti-HCC effect of α-MGT is mediated by the suppression of the STAT3 signaling cascade via stabilizing SHP1 protein in an ubiquitin–proteasome-dependent manner (Supplementary Fig. 4).